US Patent 8895617 Composition and method for treating neurological disease
Patent 8895617 was granted and assigned to Adamas Pharmaceuticals, Inc. on November, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8895617 Composition and method for treating neurological disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.